mutations and complex kar yotype. It follows a linear evolution through the CLL clone through the recurrent acquisition of CDKN2A??? "???????????????????????????????????????????????"102 Conversely, a number of groups are advocating for your incorporation of novel markers, for instance a advanced karyotype55 or epigenetic subsets, 27,28 into medical